Cargando…

Amorphous Solid Dispersion Tablets Overcome Acalabrutinib pH Effect in Dogs

Calquence(®) (crystalline acalabrutinib), a commercially marketed tyrosine kinase inhibitor (TKI), exhibits significantly reduced oral exposure when taken with acid-reducing agents (ARAs) due to the low solubility of the weakly basic drug at elevated gastric pH. These drug–drug interactions (DDIs) n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mudie, Deanna M., Stewart, Aaron M., Rosales, Jesus A., Biswas, Nishant, Adam, Molly S., Smith, Adam, Craig, Christopher D., Morgen, Michael M., Vodak, David T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071435/ https://www.ncbi.nlm.nih.gov/pubmed/33921109 http://dx.doi.org/10.3390/pharmaceutics13040557

Ejemplares similares

In Vitro-In Silico Tools for Streamlined Development of Acalabrutinib Amorphous Solid Dispersion Tablets
por: Mudie, Deanna M., et al.
Publicado: (2021)

Correction: Mudie et al. In Vitro-In Silico Tools for Streamlined Development of Acalabrutinib Amorphous Solid Dispersion Tablets. Pharmaceutics 2021, 13, 1257
por: Mudie, Deanna M., et al.
Publicado: (2021)

A novel architecture for achieving high drug loading in amorphous spray dried dispersion tablets
por: Mudie, Deanna M., et al.
Publicado: (2020)

Water-Induced Phase Separation of Spray-Dried Amorphous Solid Dispersions
por: Li, Na, et al.
Publicado: (2020)

Homogenization of Amorphous Solid Dispersions Prepared by Electrospinning in Low-Dose Tablet Formulation
por: Fülöp, Gergő, et al.
Publicado: (2018)

Orally Disintegrating Tablets Containing Melt Extruded Amorphous Solid Dispersion of Tacrolimus for Dissolution Enhancement
por: Ponnammal, Poovizhi, et al.
Publicado: (2018)

Spray-Dried Paracetamol/Polyvinylpyrrolidone Amorphous Solid Dispersions: Part I—Stability of Powders and Tablets
por: Ritters, Lena, et al.
Publicado: (2021)

Acetic Acid as Processing Aid Dramatically Improves Organic Solvent Solubility of Weakly Basic Drugs for Spray Dried Dispersion Manufacture
por: Adam, Molly S., et al.
Publicado: (2022)

Acalabrutinib: Disseminated aspergillosis: case report
Publicado: (2022)

Itraconazole Amorphous Solid Dispersion Tablets: Formulation and Compaction Process Optimization Using Quality by Design Principles and Tools
por: Triboandas, Hetvi, et al.
Publicado: (2022)

Amorphous Nanoparticulate Formulation of Sirolimus and Its Tablets
por: Shen, Yudong, et al.
Publicado: (2018)

Assessment of the stability of co-amorphous olanzapine in tablets
por: da Costa, Nuno F., et al.
Publicado: (2021)

Aqueous and pH dependent coacervation method for taste masking of paracetamol via amorphous solid dispersion formation
por: Al-kasmi, Basheer, et al.
Publicado: (2021)

Downstream Processing of Itraconazole:HPMCAS Amorphous Solid Dispersion: From Hot-Melt Extrudate to Tablet Using a Quality by Design Approach
por: Mishra, Saurabh M, et al.
Publicado: (2022)

The role of acalabrutinib in adults with chronic lymphocytic leukemia
por: Fakhri, Bita, et al.
Publicado: (2021)

NICE recommends acalabrutinib for chronic lymphocytic leukaemia
Publicado: (2021)

PB1861: ACALABRUTINIB IN THE TREATMENT OF RICHTER SYNDROME
por: Byalik, T., et al.
Publicado: (2022)

PB1948: ACALABRUTINIB IN THE TREATMENT OF RICHTER SYNDROME
por: Byalik, Tatyana, et al.
Publicado: (2023)

Correction: Adam et al. Acetic Acid as Processing Aid Dramatically Improves Organic Solvent Solubility of Weakly Basic Drugs for Spray Dried Dispersion Manufacture. Pharmaceutics 2022, 14, 555
por: Adam, Molly S., et al.
Publicado: (2022)

Design, development, and characterization of amorphous rosuvastatin calcium tablets
por: González, Rocío, et al.
Publicado: (2022)

Thermal Stability of Amorphous Solid Dispersions
por: Jelić, Dijana
Publicado: (2021)

Acalabrutinib for mantle cell lymphoma, chronic lymphocytic leukaemia
Publicado: (2020)

Differences and similarities in the effects of ibrutinib and acalabrutinib on platelet functions
por: Series, Jennifer, et al.
Publicado: (2019)

Acalabrutinib in management of chronic lymphocytic leukemia: An Indian perspective
por: Sood, Nitin, et al.
Publicado: (2021)

Acalabrutinib in Membranous Nephropathy Associated With Chronic Lymphocytic Leukemia
por: Izzedine, Hassan, et al.
Publicado: (2022)

Pirtobrutinib results in reversible platelet dysfunction compared to ibrutinib and acalabrutinib
por: Bye, Alexander P., et al.
Publicado: (2022)

Characterization of Amorphous Solid Dispersion of Pharmaceutical Compound with pH-Dependent Solubility Prepared by Continuous-Spray Granulator
por: Tanaka, Ryoma, et al.
Publicado: (2019)

Relative bioavailability of ertugliflozin tablets containing the amorphous form versus tablets containing the cocrystal form
por: Sahasrabudhe, Vaishali, et al.
Publicado: (2022)

Developing pH-Modulated Spray Dried Amorphous Solid Dispersion of Candesartan Cilexetil with Enhanced In Vitro and In Vivo Performance
por: Poudel, Surendra, et al.
Publicado: (2021)

Targeted Treatment of Chronic Lymphocytic Leukemia: Clinical Utility of Acalabrutinib
por: Vitale, Candida, et al.
Publicado: (2021)

Oral Delivery of Niclosamide as an Amorphous Solid Dispersion That Generates Amorphous Nanoparticles during Dissolution
por: Jara, Miguel O., et al.
Publicado: (2022)

Enteric coating of tablets containing an amorphous solid dispersion of an enteric polymer and a weakly basic drug: A strategy to enhance in vitro release
por: Nguyen, Hanh Thuy, et al.
Publicado: (2023)

PB1890: ZANUBRUTINIB IN ACALABRUTINIB-INTOLERANT PATIENTS (PTS) WITH B-CELL MALIGNANCIES
por: Shadman, M., et al.
Publicado: (2022)

Formulation Characterization and Pharmacokinetic Evaluation of Amorphous Solid Dispersions of Dasatinib
por: Dharani, Sathish, et al.
Publicado: (2022)

Formulation and Evaluation of Loperamide HCl Oro Dispersible Tablets
por: Alejandro, Blasco, et al.
Publicado: (2020)

Distinct Effects of Ibrutinib and Acalabrutinib on Mouse Atrial and Sinoatrial Node Electrophysiology and Arrhythmogenesis
por: Tuomi, Jari M., et al.
Publicado: (2021)

Kinetics of Water-Induced Amorphous Phase Separation in Amorphous Solid Dispersions via Raman Mapping
por: Krummnow, Adrian, et al.
Publicado: (2023)

Fluoroquinolone Amorphous Polymeric Salts and Dispersions for Veterinary Uses
por: Mesallati, Hanah, et al.
Publicado: (2019)

Cellulose based polymers in development of amorphous solid dispersions
por: Chavan, Rahul B, et al.
Publicado: (2019)

Preparation and Characterization of Amorphous Solid Dispersions for the Solubilization of Fenretinide
por: Zuccari, Guendalina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_iqnra07c2jtvdou1bvacvtn9n2